OUTBREAKS OF SCARLET FEVER IN KINDERGARTENS IN BELGRADE
Abstract
Introduction/Aim: Scarlet fever is mostly a childhood disease and in about 90% of cases it occurs in children younger than 10 years. Outbreaks of scarlet fever always occur in children’s collectives (kindergartens, schools and institutions for children). The aim of this paper is to analyze the epidemiological characteristics of scarlet fever epidemics in kindergartens in Belgrade during the five-year period (2016-2020).
Methods: Data about new cases of scarlet fever were collected for the observed period from the City Institute for Public Health Belgrade. The data sources used are: epidemiological questionnaire, medical documentation and laboratory results. The presence of β-hemolytic streptococcus group A in diseased children was proven by bacteriological analysis of throat and nose swabs. General and specific incidence rates were used in the data analysis.
Results: During the observed five-year period, 30 epidemics of scarlet fever were registered, in which a total of 114 children from 23 Belgrade kindergartens became ill. In 2017, there were 12 epidemics with a total of 49 cases, which represents the largest total number of cases in one year. In the period from 2016 to 2020, the highest number of patients among all patients with scarlet fever was among children aged 4 years (33.3%), and the lowest among children aged 2 years (1.7%). There were slightly more sick boys (57.9%) than girls (42.1%). The highest average five-year incidence rates for scarlet fever were recorded at the age 1-4 (383.7 per 100,000) and 5-9 years (262.8 per 100,000), and the lowest were in persons aged 15 and over. About 1/3 of sick children were registered in the municipality of New Belgrade, and about 1/3 of sick children were registered in the period of early spring (March-April).
Conclusion: Respect and timely application of anti-epidemic measures contribute to the successful cessation of further spread of infection (disease reporting, isolation, treatment of sick children, as well as stricter hygiene measures and ongoing disinfection).
References
Benenson AS. Control of Communicable diseases manuel. Sixteenth edition.
USA: American Public Health Association;
Public Health England. Scarlet fever: symptoms, diagnosis and treatment. Scarlet fever. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/790943/
Centers for Disease Control and Prevention. Group A Streptococcal (GAS) Disease. Scarlet fever. Treatment. Available at: https://www.cdc.gov/groupastrep/diseases-hcp/scarlet-fever.html
Public Health England. Guidelines for the public health management of scarlet fever outbreaks in schools, nurseries and other childcare settings October 2017. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/771139/
Ferretti J, Köhler W. History of Streptococcal Research. 2016. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016. Available from: https://www.ncbi.nlm.nih.gov/books/NBK333430/>
Lamagni T, Guy R, Chand M, Henderson KL, Chalker V, Lewis J, et al. Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. Lancet Infect Dis 2018; 18(2):180-187.
Institut za javno zdravlje Srbije “Dr Milan Jovanović Batut”. Izveštaj o zaraznim bolestima u Republici Srbiji za 2019. godinu. Available at: https://www.batut.org. rs/download/izvestaji/Godisnji%20izvestaj%20o%20 zaraznim%20bolestima%202019.pdf
Brockmann SO, Eichner L, Eichner M. Constantly high incidence of scarlet fever in Germany. Lancet Infect Dis 2018; 18(5):499-500.
Andrey DO, Posfay-Barbe KM. Re-emergence of scarlet fever: old players return? Expert Rev Anti Infect Ther 2016; 14(8):687-9.
Lee CF, Cowling BJ, Lau EHY. Epidemiology of Reemerging Scarlet Fever, Hong Kong, 2005-2015. Emerg Infect Dis 2017;23(10):1707-1710.
Czarkowski MP, Staszewska E, Kondej B. Scarlet fever in Poland in 2013. Przegl Epidemiol 2015; 69(2):223-7, 349- 52. English, Polish.
Kim J, Kim JE, Bae JM. Incidence of Scarlet Fever in Children in Jeju Province, Korea, 2002-2016: An Ageperiod-cohort Analysis. J Prev Med Public Health 2019; 52(3):188-194.
Qinbao Lu, Haocheng Wu, Zheyuan Ding, Chen Wu, and Junfen Lin. Analysis of Epidemiological Characteristics of Scarlet Fever in Zhejiang Province, China, 2004-2018. Int J Environ Res Public Health 2019; 16(18):3454.
Oliver J, Thielemans E, McMinn A Baker C, Britton PN, Clark JE, et al. Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study [published correction appears in BMC Public Health 2021; 21(1):855].
Oliver J, Thielemans E, McMinn A, Baker C, Britton PN, Clark JE. et al. Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study. BMC Public Health 2019; 19:1750.
Jing Wang, Jun-Qing Zhang, Hai-Feng Pan, Yu Zhu, Qian He. Epidemiological investigation of scarlet fever in Hefei City, China, from 2004 to 2008. Trop Doct 2010; 40(4):225-6.
Chen H, Chen Y, Sun B, Wen L, An X. Epidemiological study of scarlet fever in Shenyang, China. BMC Infect Dis 2019; 19(1):1074.
Saad NJ, Muller N, Walter J, Murajda L. Scarlet fever outbreak in a primary and middle school in Germany: importance of case ascertainment and risk communication. Epidemiol Infect 2020; 148:e278.
Ryu S, Chun BC. Investigation of Scarlet Fever Outbreak in a Kindergarten. Infect Chemother 2018; 50(1):38-42.